首页 > 最新文献

British Journal of Biomedical Science最新文献

英文 中文
Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update. 细菌持久细胞与慢性感染中抗生素耐药性的发展:最新进展。
IF 2.7 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-08-07 eCollection Date: 2024-01-01 DOI: 10.3389/bjbs.2024.12958
Anil Philip Kunnath, Mohamed Suodha Suoodh, Dinesh Kumar Chellappan, Jestin Chellian, Kishneth Palaniveloo

The global issue of antimicrobial resistance poses significant challenges to public health. The World Health Organization (WHO) has highlighted it as a major global health threat, causing an estimated 700,000 deaths worldwide. Understanding the multifaceted nature of antibiotic resistance is crucial for developing effective strategies. Several physiological and biochemical mechanisms are involved in the development of antibiotic resistance. Bacterial cells may escape the bactericidal actions of the drugs by entering a physiologically dormant state known as bacterial persistence. Recent findings in this field suggest that bacterial persistence can be one of the main sources of chronic infections. The antibiotic tolerance developed by the persister cells could tolerate high levels of antibiotics and may give rise to persister offspring. These persister offspring could be attributed to antibiotic resistance mechanisms, especially in chronic infections. This review attempts to shed light on persister-induced antibiotic resistance and the current therapeutic strategies.

抗菌药耐药性这一全球性问题给公共卫生带来了重大挑战。世界卫生组织(WHO)强调,抗生素耐药性是一个重大的全球健康威胁,估计会导致全球 70 万人死亡。了解抗生素耐药性的多面性对于制定有效的战略至关重要。抗生素耐药性的产生涉及多种生理和生化机制。细菌细胞可能会进入一种生理休眠状态,即细菌持续存在状态,从而逃避药物的杀菌作用。该领域的最新研究结果表明,细菌持久存在可能是慢性感染的主要来源之一。持久细胞产生的抗生素耐受性可以耐受高浓度的抗生素,并可能产生持久细胞后代。这些宿主后代可能是抗生素耐药性机制的产物,尤其是在慢性感染中。本综述试图阐明持久性细胞诱导的抗生素耐药性和当前的治疗策略。
{"title":"Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update.","authors":"Anil Philip Kunnath, Mohamed Suodha Suoodh, Dinesh Kumar Chellappan, Jestin Chellian, Kishneth Palaniveloo","doi":"10.3389/bjbs.2024.12958","DOIUrl":"10.3389/bjbs.2024.12958","url":null,"abstract":"<p><p>The global issue of antimicrobial resistance poses significant challenges to public health. The World Health Organization (WHO) has highlighted it as a major global health threat, causing an estimated 700,000 deaths worldwide. Understanding the multifaceted nature of antibiotic resistance is crucial for developing effective strategies. Several physiological and biochemical mechanisms are involved in the development of antibiotic resistance. Bacterial cells may escape the bactericidal actions of the drugs by entering a physiologically dormant state known as bacterial persistence. Recent findings in this field suggest that bacterial persistence can be one of the main sources of chronic infections. The antibiotic tolerance developed by the persister cells could tolerate high levels of antibiotics and may give rise to persister offspring. These persister offspring could be attributed to antibiotic resistance mechanisms, especially in chronic infections. This review attempts to shed light on persister-induced antibiotic resistance and the current therapeutic strategies.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":"81 ","pages":"12958"},"PeriodicalIF":2.7,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11335562/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: FIT Sensitivity-A Clinical Perspective. 致编辑的信:FIT 敏感性--临床视角。
IF 2.7 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-07-26 eCollection Date: 2024-01-01 DOI: 10.3389/bjbs.2024.13444
Eddie Cole, Deepa Narayanan, Ree Nee Tiam, John Shepherd, Mark O R Hajjawi
{"title":"Letter to the Editor: FIT Sensitivity-A Clinical Perspective.","authors":"Eddie Cole, Deepa Narayanan, Ree Nee Tiam, John Shepherd, Mark O R Hajjawi","doi":"10.3389/bjbs.2024.13444","DOIUrl":"10.3389/bjbs.2024.13444","url":null,"abstract":"","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":"81 ","pages":"13444"},"PeriodicalIF":2.7,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11312947/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141916109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: Faecal Immunochemical Test (FIT) Sensitivity: A Five Year Audit. 致编辑的信:粪便免疫化学检验 (FIT) 灵敏度:五年审计。
IF 2.7 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-07-26 eCollection Date: 2024-01-01 DOI: 10.3389/bjbs.2024.13381
Waseem Jerjes
{"title":"Letter to the Editor: Faecal Immunochemical Test (FIT) Sensitivity: A Five Year Audit.","authors":"Waseem Jerjes","doi":"10.3389/bjbs.2024.13381","DOIUrl":"10.3389/bjbs.2024.13381","url":null,"abstract":"","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":"81 ","pages":"13381"},"PeriodicalIF":2.7,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11312948/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141916108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Peer Review Process: Past, Present, and Future. 同行评审程序:过去、现在和未来。
IF 2.7 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-06-17 eCollection Date: 2024-01-01 DOI: 10.3389/bjbs.2024.12054
John A Drozdz, Michael R Ladomery

The peer review process is a fundamental aspect of modern scientific paper publishing, underpinning essential quality control. First conceptualised in the 1700s, it is an iterative process that aims to elevate scientific literature to the highest standards whilst preventing publication of scientifically unsound, potentially misleading, and even plagiarised information. It is widely accepted that the peer review of scientific papers is an irreplaceable and fundamental aspect of the research process. However, the rapid growth of research and technology has led to a huge increase in the number of publications. This has led to increased pressure on the peer review system. There are several established peer review methodologies, ranging from single and double blind to open and transparent review, but their implementation across journals and research fields varies greatly. Some journals are testing entirely novel approaches (such as collaborative reviews), whilst others are piloting changes to established methods. Given the unprecedented growth in publication numbers, and the ensuing burden on journals, editors, and reviewers, it is imperative to improve the quality and efficiency of the peer review process. Herein we evaluate the peer review process, from its historical origins to current practice and future directions.

同行评审过程是现代科学论文出版的一个基本方面,是基本质量控制的基础。它是一个反复进行的过程,旨在将科学文献提升到最高标准,同时防止发表不科学、可能误导甚至剽窃的信息。人们普遍认为,科学论文的同行评审是研究过程中不可替代的基本环节。然而,科研和技术的飞速发展导致了论文数量的激增。这给同行评审制度带来了更大的压力。目前有几种成熟的同行评审方法,从单盲、双盲到公开透明的评审,但在不同期刊和研究领域的实施情况却大相径庭。一些期刊正在测试全新的方法(如合作评审),而另一些期刊则在试行改变既定方法。鉴于出版数量的空前增长,以及期刊、编辑和审稿人随之而来的负担,提高同行评审过程的质量和效率势在必行。在此,我们将从同行评审的历史渊源、当前实践和未来方向对其进行评估。
{"title":"The Peer Review Process: Past, Present, and Future.","authors":"John A Drozdz, Michael R Ladomery","doi":"10.3389/bjbs.2024.12054","DOIUrl":"10.3389/bjbs.2024.12054","url":null,"abstract":"<p><p>The peer review process is a fundamental aspect of modern scientific paper publishing, underpinning essential quality control. First conceptualised in the 1700s, it is an iterative process that aims to elevate scientific literature to the highest standards whilst preventing publication of scientifically unsound, potentially misleading, and even plagiarised information. It is widely accepted that the peer review of scientific papers is an irreplaceable and fundamental aspect of the research process. However, the rapid growth of research and technology has led to a huge increase in the number of publications. This has led to increased pressure on the peer review system. There are several established peer review methodologies, ranging from single and double blind to open and transparent review, but their implementation across journals and research fields varies greatly. Some journals are testing entirely novel approaches (such as collaborative reviews), whilst others are piloting changes to established methods. Given the unprecedented growth in publication numbers, and the ensuing burden on journals, editors, and reviewers, it is imperative to improve the quality and efficiency of the peer review process. Herein we evaluate the peer review process, from its historical origins to current practice and future directions.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":"81 ","pages":"12054"},"PeriodicalIF":2.7,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11215012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141475923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Faecal Immunochemical Test (FIT) Sensitivity; A Five Year Audit. 粪便免疫化学检验 (FIT) 灵敏度;五年审计。
IF 2.7 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-05-29 eCollection Date: 2024-01-01 DOI: 10.3389/bjbs.2024.12862
Eddie Cole, Deepa Narayanan, Ree Nee Tiam, John Shepherd, Mark O R Hajjawi

Introduction: Colorectal cancer has a high prevalence and mortality rate in the United Kingdom. Cancerous colorectal lesions often bleed into the gastrointestinal lumen. The faecal immunochemical test (FIT) detects haemoglobin (Hb) in the faeces of patients and is used as a first line test in the diagnosis of colorectal cancer. Materials and Methods: A retrospective audit of all FIT performed and all colorectal cancers diagnosed in the Hull and East Riding of Yorkshire counties of the United Kingdom (population approximately 609,300) between 2018 and 2022 was conducted. FIT were performed using a HM-JACKarc analyser from Kyowa medical. The predominant symptom suggestive of colorectal cancer which prompted the FIT was recorded. Colorectal cancer was diagnosed using the gold standard of histological biopsy following colonoscopy. Results: Between 2018 and 2022, 56,202 FIT were performed on symptomatic patients. Follow on testing identified 1,511 with colorectal cancer. Of these people, only 450 people with a confirmed colorectal cancer had a FIT within the 12 months preceding their diagnosis. Of these 450 FIT results, 36 had a concentration of <10 μg/g and may be considered to be a false negative. The sensitivity of FIT in the patients identified was 92.00%. The most common reason stated by the clinician for a FIT being performed in patients with colorectal cancer was a change in bowel habits, followed by iron deficient anaemia. The number of patients diagnosed with colorectal cancer decreased in 2020, but increased significantly in 2021. Discussion: This study shows that 8.00% of people diagnosed with colorectal cancer in the Hull and East Riding of Yorkshire regions had a negative FIT. This study also shows that the SARS-CoV-2 pandemic affected the number of people diagnosed with colorectal cancer, and therefore skews the prevalence and pre-test probability of a positive test. There are many reasons why a FIT could produce a false negative result, the most likely being biological factors affecting the stability of haemoglobin within the gastrointestinal tract, or pre-analytical factors influencing faecal sampling preventing the detection of haemoglobin. Some colorectal lesions do not protrude into the gastrointestinal lumen and are less likely to bleed. Conclusion: This is the first study showing data from outside of a structured clinical trial and provides the largest study to date showing the sensitivity of FIT in a routine clinical setting. This study also provides evidence for the impact COVID-19 had on the rate of colorectal cancer diagnosis.

导言:大肠癌在英国的发病率和死亡率都很高。结肠直肠癌病变通常会向胃肠腔内出血。粪便免疫化学检验(FIT)可检测患者粪便中的血红蛋白(Hb),是诊断结直肠癌的一线检验方法。材料和方法:对英国赫尔郡和东约克郡(人口约 60.93 万)在 2018 年至 2022 年期间进行的所有 FIT 和诊断出的所有结直肠癌进行了回顾性审核。FIT使用Kyowa medical的HM-JACKarc分析仪进行。记录了提示进行 FIT 的结直肠癌主要症状。结肠直肠癌的诊断采用结肠镜检查后组织学活检的黄金标准。结果:2018 年至 2022 年期间,对有症状的患者进行了 56202 次 FIT。后续检测发现了 1511 名结直肠癌患者。其中,只有 450 名确诊结直肠癌的患者在确诊前 12 个月内进行了 FIT 检查。在这 450 份 FIT 结果中,有 36 份的讨论浓度较高:这项研究表明,在赫尔和约克郡东骑兵地区,8.00% 的确诊大肠癌患者的 FIT 结果为阴性。这项研究还表明,SARS-CoV-2 大流行影响了被诊断患有结直肠癌的人数,因此偏离了阳性检测的流行率和检测前概率。FIT 可能产生假阴性结果的原因有很多,最有可能的是生物因素影响了血红蛋白在胃肠道内的稳定性,或分析前因素影响了粪便取样,从而阻碍了血红蛋白的检测。有些结肠直肠病变不会突出到胃肠腔内,出血的可能性较小。结论:这是第一项显示结构化临床试验以外数据的研究,也是迄今为止显示常规临床环境中 FIT 敏感性的最大规模研究。这项研究还为 COVID-19 对结直肠癌诊断率的影响提供了证据。
{"title":"Faecal Immunochemical Test (FIT) Sensitivity; A Five Year Audit.","authors":"Eddie Cole, Deepa Narayanan, Ree Nee Tiam, John Shepherd, Mark O R Hajjawi","doi":"10.3389/bjbs.2024.12862","DOIUrl":"10.3389/bjbs.2024.12862","url":null,"abstract":"<p><p><b>Introduction:</b> Colorectal cancer has a high prevalence and mortality rate in the United Kingdom. Cancerous colorectal lesions often bleed into the gastrointestinal lumen. The faecal immunochemical test (FIT) detects haemoglobin (Hb) in the faeces of patients and is used as a first line test in the diagnosis of colorectal cancer. <b>Materials and Methods:</b> A retrospective audit of all FIT performed and all colorectal cancers diagnosed in the Hull and East Riding of Yorkshire counties of the United Kingdom (population approximately 609,300) between 2018 and 2022 was conducted. FIT were performed using a HM-JACKarc analyser from Kyowa medical. The predominant symptom suggestive of colorectal cancer which prompted the FIT was recorded. Colorectal cancer was diagnosed using the gold standard of histological biopsy following colonoscopy. <b>Results:</b> Between 2018 and 2022, 56,202 FIT were performed on symptomatic patients. Follow on testing identified 1,511 with colorectal cancer. Of these people, only 450 people with a confirmed colorectal cancer had a FIT within the 12 months preceding their diagnosis. Of these 450 FIT results, 36 had a concentration of <10 μg/g and may be considered to be a false negative. The sensitivity of FIT in the patients identified was 92.00%. The most common reason stated by the clinician for a FIT being performed in patients with colorectal cancer was a change in bowel habits, followed by iron deficient anaemia. The number of patients diagnosed with colorectal cancer decreased in 2020, but increased significantly in 2021. <b>Discussion:</b> This study shows that 8.00% of people diagnosed with colorectal cancer in the Hull and East Riding of Yorkshire regions had a negative FIT. This study also shows that the SARS-CoV-2 pandemic affected the number of people diagnosed with colorectal cancer, and therefore skews the prevalence and pre-test probability of a positive test. There are many reasons why a FIT could produce a false negative result, the most likely being biological factors affecting the stability of haemoglobin within the gastrointestinal tract, or pre-analytical factors influencing faecal sampling preventing the detection of haemoglobin. Some colorectal lesions do not protrude into the gastrointestinal lumen and are less likely to bleed. <b>Conclusion:</b> This is the first study showing data from outside of a structured clinical trial and provides the largest study to date showing the sensitivity of FIT in a routine clinical setting. This study also provides evidence for the impact COVID-19 had on the rate of colorectal cancer diagnosis.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":"81 ","pages":"12862"},"PeriodicalIF":2.7,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11167630/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Supporting the Biomedical Science UG Project Research Journey Through Staff-Student Partnerships. 通过师生合作支持生物医学本科生的项目研究之旅。
IF 1.9 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-05-29 eCollection Date: 2024-01-01 DOI: 10.3389/bjbs.2024.12215
S Veuger, L Cookson, H Creighton, S Gallaher, S Racey, M Ridley, I Robson

Introduction: Developing research skills enhances graduate attributes and student employability. The UG research project is coined the pedagogy of the 21st century but the diversity of supervisory styles is a source of student perceived inequality of experience. The goal of this study was to provide structure and support to undergraduate (UG) biomedical science research students and supervisors by co-creating research informed resources that are accessible, engaging and student centred. We asked 1) How do UG students experience research supervision? 2) What approaches do supervisors use to support UG project students? 3) How do students as partners benefit from being involved in pedagogical research? Materials and Methods: In Stage One, 3 UG student research partners co-developed questionnaires and followed these up with semi-structured interviews. Fifty two UG project students took part in an interactive poll and 14 supervisors answered a questionnaire. Seven students and 4 supervisors were interviewed. These were analysed by thematic analysis. In Stage Two, the questions were asked of UG project students (n = 79) via an interactive poll and the resource developed in Stage One was trialled with students (n = 68) and supervisors (n = 37). Results: The global theme identified was that students feel strongly that the student-supervisor relationship influences their experience, satisfaction and success. In all polls, >90% of students but <60% of supervisors agree that a good student/supervisor partnership has an effect on the success of the final project. A smaller percentage of students felt strongly that they were able to develop a successful partnership with their supervisor. We co-created a visual model and a list of discussion points of how the student-supervisor partnership can be developed, aimed at making supervision more effective whilst being non-prescriptive. Discussion: The resource can be easily adapted. Students believe it helped them to develop a staff-student partnership and supervisors commented that it helps to clarify roles and manage student expectations. This scalable project will support the practice of future UG biomedical science project research students and supervisors. Working with students as partners enabled the development of richer ideas whilst supporting their employability.

简介培养研究技能可以提高毕业生的素质和就业能力。本科生研究项目被誉为 21 世纪的教学法,但督导风格的多样性是学生认为经验不平等的根源。本研究的目标是通过共同创建可访问、有吸引力和以学生为中心的研究资源,为本科生(UG)生物医学科学研究学生和导师提供结构和支持。我们的问题是:1)本科生如何体验研究督导?2) 导师采用什么方法支持本科项目学生?3) 作为合作伙伴,学生如何从参与教学研究中获益?材料与方法:在第一阶段,3 名大学本科生研究伙伴共同编制了调查问卷,并进行了半结构式访谈。52 名本科项目学生参加了互动投票,14 名导师回答了问卷。7 名学生和 4 名导师接受了访谈。对这些问卷进行了专题分析。在第二阶段,通过互动投票向 UG 项目学生(n = 79)提出了问题,并向学生(n = 68)和督导(n = 37)试用了第一阶段开发的资源。结果:确定的总体主题是,学生强烈认为学生与督导的关系会影响他们的经历、满意度和成功。在所有民意调查中,超过 90% 的学生赞成讨论:该资源很容易调整。学生认为这有助于他们发展师生伙伴关系,而督导则认为这有助于澄清角色和管理学生的期望。这个可扩展的项目将支持未来大学本科生生物医学科学项目研究学生和导师的实践。与学生作为合作伙伴一起工作,能够开发出更丰富的想法,同时支持他们的就业能力。
{"title":"Supporting the Biomedical Science UG Project Research Journey Through Staff-Student Partnerships.","authors":"S Veuger, L Cookson, H Creighton, S Gallaher, S Racey, M Ridley, I Robson","doi":"10.3389/bjbs.2024.12215","DOIUrl":"10.3389/bjbs.2024.12215","url":null,"abstract":"<p><p><b>Introduction:</b> Developing research skills enhances graduate attributes and student employability. The UG research project is coined the pedagogy of the 21st century but the diversity of supervisory styles is a source of student perceived inequality of experience. The goal of this study was to provide structure and support to undergraduate (UG) biomedical science research students and supervisors by co-creating research informed resources that are accessible, engaging and student centred. We asked 1) How do UG students experience research supervision? 2) What approaches do supervisors use to support UG project students? 3) How do students as partners benefit from being involved in pedagogical research? <b>Materials and Methods:</b> In Stage One, 3 UG student research partners co-developed questionnaires and followed these up with semi-structured interviews. Fifty two UG project students took part in an interactive poll and 14 supervisors answered a questionnaire. Seven students and 4 supervisors were interviewed. These were analysed by thematic analysis. In Stage Two, the questions were asked of UG project students (<i>n</i> = 79) via an interactive poll and the resource developed in Stage One was trialled with students (<i>n</i> = 68) and supervisors (<i>n</i> = 37). <b>Results:</b> The global theme identified was that students feel strongly that the student-supervisor relationship influences their experience, satisfaction and success. In all polls, >90% of students but <60% of supervisors agree that a good student/supervisor partnership has an effect on the success of the final project. A smaller percentage of students felt strongly that they were able to develop a successful partnership with their supervisor. We co-created a visual model and a list of discussion points of how the student-supervisor partnership can be developed, aimed at making supervision more effective whilst being non-prescriptive. <b>Discussion:</b> The resource can be easily adapted. Students believe it helped them to develop a staff-student partnership and supervisors commented that it helps to clarify roles and manage student expectations. This scalable project will support the practice of future UG biomedical science project research students and supervisors. Working with students as partners enabled the development of richer ideas whilst supporting their employability.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":"81 ","pages":"12215"},"PeriodicalIF":1.9,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11167481/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role and Limitations of the Reference Interval Within Clinical Chemistry and Its Reliability for Disease Detection. 临床化学参考区间的作用和局限性及其对疾病检测的可靠性。
IF 1.9 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-02-28 eCollection Date: 2024-01-01 DOI: 10.3389/bjbs.2024.12339
Nathan E Timbrell

Reference intervals (RIs) are a range of values that are supplied alongside laboratory measurements for comparison to allow interpretation of this data. Historically, RIs were referred to as the normal range. However, the perception of what is normal can lead to confusion in clinicians and unnecessary emotional distress in patients. RIs can be acquired using several methods. Laboratories may quote published studies or derive their own using established direct or indirect methods. Alternatively, laboratories may verify RIs provided by assay manufacturers using in-house studies. RIs have several limitations that clinicians should be aware of. The statistical methodology associated with establishment of RIs means that approximately 5% of "disease free" individuals will fall outside the RI. Additionally, the higher the number of tests requested, the higher the probability that one will be abnormal, and repeat results in an individual may show regression to the mean. Completion of studies for establishment of RIs can be expensive, difficult, and time consuming. Method bias and differences in populations can greatly influence RIs and prevent them from being transferable between some laboratories. Differences in individual characteristics such as age, ethnicity, and sex can result in large variation in some analytes. Some patients, such as those whose gender differs from that which was presumed for them at birth, may require their own RIs. Alternatively, a decision will need to be made about which to use. Overall, the issue common to these factors lies within interpretation. As such, RIs can be improved with better training in their use, combined with a better understanding of influences that affect them, and more transparent communication from laboratories in how RIs were derived.

参考区间(RIs)是与实验室测量结果一起提供的数值范围,用于比较以解释这些数据。从历史上看,参考区间被称为正常范围。然而,对正常值的认识可能会导致临床医生的困惑和患者不必要的情绪困扰。RIs 可通过多种方法获得。实验室可引用已发表的研究报告,或使用已确立的直接或间接方法自行推导。另外,实验室也可以通过内部研究来验证化验生产商提供的 RIs。RIs 有几个局限性,临床医生应加以注意。与确定 RI 相关的统计方法意味着约有 5% 的 "无病 "个体会在 RI 范围之外。此外,要求进行的检测次数越多,其中一次出现异常的概率就越高,而且一个人的重复检测结果可能会向平均值回归。完成用于确定 RI 的研究可能既昂贵、困难又耗时。方法偏差和人群差异会极大地影响 RIs,并使其无法在某些实验室之间转移。年龄、种族和性别等个体特征的差异会导致某些分析物的差异很大。有些患者,如性别与出生时的假定性别不同的患者,可能需要自己的 RI。另外,还需要决定使用哪种 RI。总之,这些因素的共同问题在于解释。因此,如果在使用 RI 方面进行更好的培训,同时更好地了解影响 RI 的各种因素,并让实验室就如何得出 RI 进行更透明的交流,那么 RI 就能得到改善。
{"title":"The Role and Limitations of the Reference Interval Within Clinical Chemistry and Its Reliability for Disease Detection.","authors":"Nathan E Timbrell","doi":"10.3389/bjbs.2024.12339","DOIUrl":"10.3389/bjbs.2024.12339","url":null,"abstract":"<p><p>Reference intervals (RIs) are a range of values that are supplied alongside laboratory measurements for comparison to allow interpretation of this data. Historically, RIs were referred to as the normal range. However, the perception of what is normal can lead to confusion in clinicians and unnecessary emotional distress in patients. RIs can be acquired using several methods. Laboratories may quote published studies or derive their own using established direct or indirect methods. Alternatively, laboratories may verify RIs provided by assay manufacturers using in-house studies. RIs have several limitations that clinicians should be aware of. The statistical methodology associated with establishment of RIs means that approximately 5% of \"disease free\" individuals will fall outside the RI. Additionally, the higher the number of tests requested, the higher the probability that one will be abnormal, and repeat results in an individual may show regression to the mean. Completion of studies for establishment of RIs can be expensive, difficult, and time consuming. Method bias and differences in populations can greatly influence RIs and prevent them from being transferable between some laboratories. Differences in individual characteristics such as age, ethnicity, and sex can result in large variation in some analytes. Some patients, such as those whose gender differs from that which was presumed for them at birth, may require their own RIs. Alternatively, a decision will need to be made about which to use. Overall, the issue common to these factors lies within interpretation. As such, RIs can be improved with better training in their use, combined with a better understanding of influences that affect them, and more transparent communication from laboratories in how RIs were derived.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":"81 ","pages":"12339"},"PeriodicalIF":1.9,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10932992/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140118734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Variants Associated With Response to Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients: A Field Synopsis and Meta-Analysis. 与非小细胞肺癌患者对铂类化疗反应相关的基因变异:现场概要和 Meta 分析。
IF 1.9 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-02-21 eCollection Date: 2024-01-01 DOI: 10.3389/bjbs.2024.11835
Hilary Sito, Mohamad Ayub Khan Sharzehan, Md Asiful Islam, Shing Cheng Tan

Background: Publications on the associations of genetic variants with the response to platinum-based chemotherapy (PBC) in NSCLC patients have surged over the years, but the results have been inconsistent. Here, a comprehensive meta-analysis was conducted to combine eligible studies for a more accurate assessment of the pharmacogenetics of PBC in NSCLC patients. Methods: Relevant publications were searched in PubMed, Scopus, and Web of Science databases through 15 May 2021. Inclusion criteria for eligible publications include studies that reported genotype and allele frequencies of NSCLC patients treated with PBC, delineated by their treatment response (sensitive vs. resistant). Publications on cell lines or animal models, duplicate reports, and non-primary research were excluded. Epidemiological credibility of cumulative evidence was assessed using the Newcastle-Ottawa Scale (NOS) and Venice criteria. Begg's and Egger's tests were used to assess publication bias. Cochran's Q-test and I2 test were used to calculate the odds ratio and heterogeneity value to proceed with the random effects or fixed-effects method. Venice criteria were used to assess the strength of evidence, replication methods and protection against bias in the studies. Results: A total of 121 publications comprising 29,478 subjects were included in this study, and meta-analyses were performed on 184 genetic variants. Twelve genetic variants from 10 candidate genes showed significant associations with PBC response in NSCLC patients with strong or moderate cumulative epidemiological evidence (increased risk: ERCC1 rs3212986, ERCC2 rs1799793, ERCC2 rs1052555, and CYP1A1 rs1048943; decreased risk: GSTM1 rs36631, XRCC1 rs1799782 and rs25487, XRCC3 rs861539, XPC rs77907221, ABCC2 rs717620, ABCG2 rs2231142, and CDA rs1048977). Bioinformatics analysis predicted possible damaging or deleterious effects for XRCC1 rs1799782 and possible low or medium functional impact for CYP1A1 rs1048943. Conclusion: Our results provide an up-to-date summary of the association between genetic variants and response to PBC in NSCLC patients.

背景:多年来,关于基因变异与 NSCLC 患者铂类化疗(PBC)反应相关性的文献激增,但结果并不一致。在此,我们进行了一项全面的荟萃分析,以合并符合条件的研究,从而更准确地评估 NSCLC 患者 PBC 的药物遗传学。研究方法截至 2021 年 5 月 15 日,在 PubMed、Scopus 和 Web of Science 数据库中检索了相关出版物。符合条件的出版物的纳入标准包括报告了接受 PBC 治疗的 NSCLC 患者的基因型和等位基因频率的研究,并根据其治疗反应(敏感与耐药)进行了划分。不包括细胞系或动物模型、重复报告和非初步研究的出版物。累积证据的流行病学可信度采用纽卡斯尔-渥太华量表(NOS)和威尼斯标准进行评估。Begg's 和 Egger's 检验用于评估发表偏倚。科克伦 Q 检验和 I2 检验用于计算随机效应法或固定效应法的几率和异质性值。采用 Venice 标准评估研究的证据强度、复制方法和防偏倚保护。研究结果本研究共收录了 121 篇文献,涉及 29 478 名受试者,并对 184 个遗传变异进行了荟萃分析。10 个候选基因中的 12 个基因变异与 NSCLC 患者的 PBC 反应有显著关联,且有较强或中等的累积流行病学证据(风险增加:ERCC1 rs3212986、ERCC2 rs1799793、ERCC2 rs1052555 和 CYP1A1 rs1048943;风险降低:GSTM1 rs36631、XRCC1 rs1799782 和 rs25487、XRCC3 rs861539、XPC rs77907221、ABCC2 rs717620、ABCG2 rs2231142 和 CDA rs1048977)。生物信息学分析预测,XRCC1 rs1799782 可能会产生破坏性或有害影响,CYP1A1 rs1048943 可能会产生低度或中度功能影响。结论我们的研究结果提供了 NSCLC 患者基因变异与 PBC 反应之间关系的最新总结。
{"title":"Genetic Variants Associated With Response to Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients: A Field Synopsis and Meta-Analysis.","authors":"Hilary Sito, Mohamad Ayub Khan Sharzehan, Md Asiful Islam, Shing Cheng Tan","doi":"10.3389/bjbs.2024.11835","DOIUrl":"10.3389/bjbs.2024.11835","url":null,"abstract":"<p><p><b>Background:</b> Publications on the associations of genetic variants with the response to platinum-based chemotherapy (PBC) in NSCLC patients have surged over the years, but the results have been inconsistent. Here, a comprehensive meta-analysis was conducted to combine eligible studies for a more accurate assessment of the pharmacogenetics of PBC in NSCLC patients. <b>Methods:</b> Relevant publications were searched in PubMed, Scopus, and Web of Science databases through 15 May 2021. Inclusion criteria for eligible publications include studies that reported genotype and allele frequencies of NSCLC patients treated with PBC, delineated by their treatment response (sensitive vs. resistant). Publications on cell lines or animal models, duplicate reports, and non-primary research were excluded. Epidemiological credibility of cumulative evidence was assessed using the Newcastle-Ottawa Scale (NOS) and Venice criteria. Begg's and Egger's tests were used to assess publication bias. Cochran's Q-test and I<sup>2</sup> test were used to calculate the odds ratio and heterogeneity value to proceed with the random effects or fixed-effects method. Venice criteria were used to assess the strength of evidence, replication methods and protection against bias in the studies. <b>Results:</b> A total of 121 publications comprising 29,478 subjects were included in this study, and meta-analyses were performed on 184 genetic variants. Twelve genetic variants from 10 candidate genes showed significant associations with PBC response in NSCLC patients with strong or moderate cumulative epidemiological evidence (increased risk: <i>ERCC1</i> rs3212986, <i>ERCC2</i> rs1799793, <i>ERCC2</i> rs1052555, and <i>CYP1A1</i> rs1048943; decreased risk: <i>GSTM1</i> rs36631, <i>XRCC1</i> rs1799782 and rs25487, <i>XRCC3</i> rs861539, <i>XPC</i> rs77907221, <i>ABCC2</i> rs717620, <i>ABCG2</i> rs2231142, and <i>CDA</i> rs1048977). Bioinformatics analysis predicted possible damaging or deleterious effects for <i>XRCC1</i> rs1799782 and possible low or medium functional impact for <i>CYP1A1</i> rs1048943. <b>Conclusion:</b> Our results provide an up-to-date summary of the association between genetic variants and response to PBC in NSCLC patients.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":"81 ","pages":"11835"},"PeriodicalIF":1.9,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914946/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140048787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Measuring the Impact of Incorporating Case Study Presentations Into Applied Biomedical Science Placement Workshops for Trainee Biomedical Scientists. 衡量将案例研究演示纳入生物医学科学应用实习研讨会对生物医学科学实习生的影响。
IF 1.9 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-02-20 eCollection Date: 2024-01-01 DOI: 10.3389/bjbs.2024.12017
Amreen Bashir, Kathryn Dudley, Karan Singh Rana, Kayleigh Wilkins, Ross Pallett

Introduction: Successfully completing the Institute of Biomedical Science (IBMS) registration portfolio is essential to becoming a Health and Care Professions Council (HCPC) registered Biomedical Scientist. In the West Midlands, a unique collaboration between four universities (Aston, Wolverhampton, Coventry, and Keele) and local NHS Trusts supports student placements and portfolio development. The universities support Training Officers in delivering components of the registration portfolio through the delivery of eight combined placement workshops. These have been designed to align to the IBMS registration portfolio and help students meet the HCPC Standards of Proficiency. This study aimed to evaluate the effectiveness of a redesigned workshop where students generated and presented medical case studies to peers, academics, and training leads. Materials and Methods: The three phases of the case study intervention included a pre-intervention survey, academic-led sessions focussing on medical case presentations and delivery of the presentation followed by a post-intervention survey. Results: Analysing survey responses pre- and post-intervention, students demonstrated enhanced confidence in their understanding of clinical conditions (p<0.0001), connecting lab findings to diseases, and in delivering a case presentation to their peers (p<0.001). Students reported an increased confidence in structuring case presentations and their critical thinking ability (p<0.0001). All students agreed engaging with the case study workshop improved their ability to communicate knowledge of scientific concepts orally. Thematic analysis revealed that the case presentation deepened students' understanding of multidisciplinary teams. 98% of respondents agreed patient communication should be integrated into Biomedical Sciences courses and 85% would like to see case study presentations embedded into the curriculum. Discussion: Combined placement workshops are an integral part of the Applied Biomedical Science placement journey. Case study presentations are clearly a valuable teaching and learning tool to nurture and develop key transferable skills and competencies in conjunction with Biomedical Science expertise. The collaborative approach in the West Midlands effectively prepares graduates with essential pathology knowledge, skills, and a completed IBMS registration portfolio. This study highlights a successful framework for a collaborative partnership with local NHS trusts that has allowed the completion of numerous pathology placements and could be adopted by other universities delivering accredited Biomedical Science courses.

简介:成功完成生物医学科学研究所(IBMS)注册组合是成为健康与护理专业委员会(HCPC)注册生物医学科学家的必要条件。在西米德兰兹郡,四所大学(阿斯顿大学、伍尔弗汉普顿大学、考文垂大学和基尔大学)与当地 NHS 信托基金会开展了一项独特的合作,为学生实习和作品集开发提供支持。这四所大学通过举办八次综合实习研讨会,支持培训官员完成注册组合的各个部分。这些工作坊的设计与 IBMS 注册组合相一致,并帮助学生达到 HCPC 能力标准。本研究旨在评估重新设计的工作坊的效果,在工作坊中,学生将生成医学案例研究并向同行、学者和培训负责人展示。材料与方法:病例研究干预分为三个阶段,包括干预前调查、以医学病例展示为重点的学术主导课程和演示交付,以及干预后调查。结果:通过分析干预前和干预后的调查反馈,学生对临床病症的理解增强了信心(ppp 讨论:综合实习研讨会是应用生物医学科学实习过程中不可或缺的一部分。案例研究演示显然是一种宝贵的教学工具,可以结合生物医学专业知识培养和发展关键的可迁移技能和能力。西米德兰兹地区的合作方法有效地培养了具备基本病理学知识、技能和完整的国际生物医学注册组合的毕业生。本研究强调了与当地 NHS 信托公司合作的一个成功框架,该框架使许多病理学实习得以完成,并可供其他开设生物医学科学认证课程的大学采用。
{"title":"Measuring the Impact of Incorporating Case Study Presentations Into Applied Biomedical Science Placement Workshops for Trainee Biomedical Scientists.","authors":"Amreen Bashir, Kathryn Dudley, Karan Singh Rana, Kayleigh Wilkins, Ross Pallett","doi":"10.3389/bjbs.2024.12017","DOIUrl":"10.3389/bjbs.2024.12017","url":null,"abstract":"<p><p><b>Introduction:</b> Successfully completing the Institute of Biomedical Science (IBMS) registration portfolio is essential to becoming a Health and Care Professions Council (HCPC) registered Biomedical Scientist. In the West Midlands, a unique collaboration between four universities (Aston, Wolverhampton, Coventry, and Keele) and local NHS Trusts supports student placements and portfolio development. The universities support Training Officers in delivering components of the registration portfolio through the delivery of eight combined placement workshops. These have been designed to align to the IBMS registration portfolio and help students meet the HCPC Standards of Proficiency. This study aimed to evaluate the effectiveness of a redesigned workshop where students generated and presented medical case studies to peers, academics, and training leads. <b>Materials and Methods:</b> The three phases of the case study intervention included a pre-intervention survey, academic-led sessions focussing on medical case presentations and delivery of the presentation followed by a post-intervention survey. <b>Results:</b> Analysing survey responses pre- and post-intervention, students demonstrated enhanced confidence in their understanding of clinical conditions (<i>p</i><0.0001), connecting lab findings to diseases, and in delivering a case presentation to their peers (<i>p</i><0.001). Students reported an increased confidence in structuring case presentations and their critical thinking ability (<i>p</i><0.0001). All students agreed engaging with the case study workshop improved their ability to communicate knowledge of scientific concepts orally. Thematic analysis revealed that the case presentation deepened students' understanding of multidisciplinary teams. 98% of respondents agreed patient communication should be integrated into Biomedical Sciences courses and 85% would like to see case study presentations embedded into the curriculum. <b>Discussion:</b> Combined placement workshops are an integral part of the Applied Biomedical Science placement journey. Case study presentations are clearly a valuable teaching and learning tool to nurture and develop key transferable skills and competencies in conjunction with Biomedical Science expertise. The collaborative approach in the West Midlands effectively prepares graduates with essential pathology knowledge, skills, and a completed IBMS registration portfolio. This study highlights a successful framework for a collaborative partnership with local NHS trusts that has allowed the completion of numerous pathology placements and could be adopted by other universities delivering accredited Biomedical Science courses.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":"81 ","pages":"12017"},"PeriodicalIF":1.9,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10912474/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140038793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Landscape View of the Female Genital Tract Microbiome in Healthy Controls and Women With Reproductive Health Conditions Associated With Ectopic Pregnancy. 健康对照组和患有与宫外孕相关的生殖健康问题的妇女的女性生殖道微生物组景观图。
IF 2.7 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-01-12 eCollection Date: 2023-01-01 DOI: 10.3389/bjbs.2023.12098
Hui En Teh, Cheng Khee Pung, Valliammai Jayanthi Thirunavuk Arasoo, Polly Soo Xi Yap

Disruption of the female genital microbiome is associated with several pregnancy complications, including miscarriage, preterm onset of labour, and tubal pregnancy. Ectopic pregnancy is a known cause of maternal morbidity and mortality, but early diagnosis and treatment of ectopic pregnancy remain a challenge. Despite growing established associations between genital microbiome and female reproductive health, few studies have specifically focused on its link with ectopic pregnancy. Therefore, the current review aims to provide a comprehensive account of the female genital microbiome in healthy and fertile women compared to those in ectopic pregnancy and its associated risk factors. The microbial diversity from various sites of the female genital tract was explored for a reliable proxy of female reproductive health in sequencing-based ectopic pregnancy research. Our report confirmed the predominance of Lactobacillus in the vagina and the cervix among healthy women. The relative abundance decreased in the vaginal and cervical microbiome in the disease state. In contrast, there were inconsistent findings on the uterine microbiome across studies. Additionally, we explore a spectrum of opportunities to enhance our understanding of the female genital tract microbiome and reproductive conditions. In conclusion, this study identifies gaps within the field and emphasises the need for visionary solutions in metagenomic tools for the early detection of ectopic pregnancy and other gynaecological diseases.

女性生殖器微生物组的破坏与多种妊娠并发症有关,包括流产、早产和输卵管妊娠。宫外孕是导致孕产妇发病和死亡的一个已知原因,但宫外孕的早期诊断和治疗仍是一个挑战。尽管生殖器微生物组与女性生殖健康之间的关系越来越密切,但很少有研究特别关注其与宫外孕的关系。因此,本综述旨在全面阐述健康和已育女性与宫外孕女性的生殖器微生物组及其相关风险因素。在基于测序的异位妊娠研究中,我们探索了女性生殖道不同部位的微生物多样性,以作为女性生殖健康的可靠代表。我们的报告证实,乳酸杆菌在健康女性的阴道和宫颈中占主导地位。在疾病状态下,阴道和宫颈微生物组中乳酸杆菌的相对丰度降低。相比之下,不同研究对子宫微生物组的发现并不一致。此外,我们还探讨了一系列机会,以增进我们对女性生殖道微生物组和生殖状况的了解。总之,这项研究找出了该领域的差距,并强调需要有远见的元基因组工具来早期检测宫外孕和其他妇科疾病。
{"title":"A Landscape View of the Female Genital Tract Microbiome in Healthy Controls and Women With Reproductive Health Conditions Associated With Ectopic Pregnancy.","authors":"Hui En Teh, Cheng Khee Pung, Valliammai Jayanthi Thirunavuk Arasoo, Polly Soo Xi Yap","doi":"10.3389/bjbs.2023.12098","DOIUrl":"10.3389/bjbs.2023.12098","url":null,"abstract":"<p><p>Disruption of the female genital microbiome is associated with several pregnancy complications, including miscarriage, preterm onset of labour, and tubal pregnancy. Ectopic pregnancy is a known cause of maternal morbidity and mortality, but early diagnosis and treatment of ectopic pregnancy remain a challenge. Despite growing established associations between genital microbiome and female reproductive health, few studies have specifically focused on its link with ectopic pregnancy. Therefore, the current review aims to provide a comprehensive account of the female genital microbiome in healthy and fertile women compared to those in ectopic pregnancy and its associated risk factors. The microbial diversity from various sites of the female genital tract was explored for a reliable proxy of female reproductive health in sequencing-based ectopic pregnancy research. Our report confirmed the predominance of <i>Lactobacillus</i> in the vagina and the cervix among healthy women. The relative abundance decreased in the vaginal and cervical microbiome in the disease state. In contrast, there were inconsistent findings on the uterine microbiome across studies. Additionally, we explore a spectrum of opportunities to enhance our understanding of the female genital tract microbiome and reproductive conditions. In conclusion, this study identifies gaps within the field and emphasises the need for visionary solutions in metagenomic tools for the early detection of ectopic pregnancy and other gynaecological diseases.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":"80 ","pages":"12098"},"PeriodicalIF":2.7,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10811206/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139569257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
British Journal of Biomedical Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1